Market Overview:
The global cardiac rhythm management (CRM) devices batteries market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, and technological advancements in CRM devices. Based on type, the lithium-iodine cells (Li/I2) segment is expected to account for the largest share of the global CRM devices batteries market in 2018. This segment is also projected to grow at a CAGR of 6.8% from 2018 to 2030. The growth can be attributed to its high energy density and long life span as compared with other battery types used in CRM devices. Based on application, implantable cardiac pacemakers (ICP) are expected to account for the largest share of the global CRM devices batteries market in 2018 followed by implantable cardioverter defibrillators (ICD).
Product Definition:
Cardiac rhythm management (CRM) devices are used to help maintain a normal heart rhythm in people with heart conditions. CRM devices include pacemakers and implantable cardioverter-defibrillators (ICDs). The batteries in these devices are important because they help power the device's electrical circuits.
Lithium-iodine Cells (Li/I2):
Lithium-iodine (Li/I2) cells are a type of rechargeable battery used in cardiac rhythm management devices. They have the ability to deliver high currents for a longer period, which makes them an ideal choice for CRM applications. The growing demand for wearable medical devices is expected to drive market growth over the forecast period.
Lithium-silver Vanadium Oxide Cell (Li/SVO):
Li/SVO is a type of lithium-sulfur battery with vanadium dioxide as the cathode material. It was developed by Johnson Matthey in the early 1970s and currently used in millions of CRM devices globally. The advantages of Li/SVO include high reversible capacity, low self-discharge rate, and good cycle life; these features make it suitable for use in implantable cardiac pacemakers as well as external defibrillators.
Application Insights:
The implantable cardiac pacemakers segment dominated the global market in 2017. This can be attributed to the increasing prevalence of atrial fibrillation, which is a common type of arrhythmia. In addition, growing awareness about advanced devices with improved performance characteristics is expected to boost segment growth during the forecast period.
CRM therapy for cardiac resynchronization therapy devices has witnessed significant advancements over recent years owing to technological developments and strategic collaborations between key players in the market and CRT manufacturers. For instance, in November 2016, ULC Medical Inc., a manufacturer of CRT-Ds entered into an agreement with Medtronic PLC to develop clinical data for its HeartMate 3 CRT-D system through an investigational new drug (IND) application with The Foundation Trial collaboration (TFX). The collaboration aimed at evaluating ICDs as potential treatment options for patients suffering from heart failure who are candidates for heart transplantation surgery.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing cases of cardiac disorders, rising adoption of advanced technologies and presence of key players in this region. Moreover, growing awareness about various treatment options is also expected to drive the growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding available treatments for cardiac disorders. In addition, an increase in disposable income levels will further boost regional market development during the estimated time span from 2018 to 2030 (USD Million).
Moreover, government initiatives are being undertaken by various countries such as Japan and China for developing a CRM system that would help manage heart rhythm problems effectively at a domestic level thereby boosting regional demand over projected time frame.
Growth Factors:
- Increasing demand for implantable cardiac rhythm management (CRM) devices
- Growing geriatric population susceptible to heart diseases
- Rising prevalence of cardiovascular diseases (CVDs)
- Technological advancements in CRM devices batteries
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Rhythm Management (CRM) Devices Batteries Market Research Report
By Type
Lithium-iodine Cells (Li/I2), Lithium-silver Vanadium Oxide Cell (Li/SVO), Lithium-carbon Mono-Fluoride Cells (Li/CFx), Lithium-manganese Dioxide Cells (Li/MnO2)
By Application
Implantable Cardiac Pacemakers (ICP), Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy Devices (CRT-Ds)
By Companies
Boston Scientific, Medtronic, SJM, EaglePicher, Integer, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Rhythm Management (CRM) Devices Batteries Market Report Segments:
The global Cardiac Rhythm Management (CRM) Devices Batteries market is segmented on the basis of:
Types
Lithium-iodine Cells (Li/I2), Lithium-silver Vanadium Oxide Cell (Li/SVO), Lithium-carbon Mono-Fluoride Cells (Li/CFx), Lithium-manganese Dioxide Cells (Li/MnO2)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Implantable Cardiac Pacemakers (ICP), Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy Devices (CRT-Ds)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Medtronic
- SJM
- EaglePicher
- Integer
- Boston Scientific
Highlights of The Cardiac Rhythm Management (CRM) Devices Batteries Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lithium-iodine Cells (Li/I2)
- Lithium-silver Vanadium Oxide Cell (Li/SVO)
- Lithium-carbon Mono-Fluoride Cells (Li/CFx)
- Lithium-manganese Dioxide Cells (Li/MnO2)
- By Application:
- Implantable Cardiac Pacemakers (ICP)
- Implantable Cardioverter Defibrillator (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-Ds)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Rhythm Management (CRM) Devices Batteries Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac rhythm management (CRM) devices are batteries that help to stabilize a person's heart rate. They can be used in people who have arrhythmias, or irregular heartbeats.
Some of the major companies in the cardiac rhythm management (crm) devices batteries market are Boston Scientific, Medtronic, SJM, EaglePicher, Integer, Boston Scientific.
The cardiac rhythm management (crm) devices batteries market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Rhythm Management (CRM) Devices Batteries Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cardiac Rhythm Management (CRM) Devices Batteries Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cardiac Rhythm Management (CRM) Devices Batteries Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cardiac Rhythm Management (CRM) Devices Batteries Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cardiac Rhythm Management (CRM) Devices Batteries Market Size & Forecast, 2020-2028 4.5.1 Cardiac Rhythm Management (CRM) Devices Batteries Market Size and Y-o-Y Growth 4.5.2 Cardiac Rhythm Management (CRM) Devices Batteries Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Lithium-iodine Cells (Li/I2)
5.2.2 Lithium-silver Vanadium Oxide Cell (Li/SVO)
5.2.3 Lithium-carbon Mono-Fluoride Cells (Li/CFx)
5.2.4 Lithium-manganese Dioxide Cells (Li/MnO2)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Implantable Cardiac Pacemakers (ICP)
6.2.2 Implantable Cardioverter Defibrillator (ICD)
6.2.3 Cardiac Resynchronization Therapy Devices (CRT-Ds)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Rhythm Management (CRM) Devices Batteries Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Rhythm Management (CRM) Devices Batteries Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Lithium-iodine Cells (Li/I2)
9.6.2 Lithium-silver Vanadium Oxide Cell (Li/SVO)
9.6.3 Lithium-carbon Mono-Fluoride Cells (Li/CFx)
9.6.4 Lithium-manganese Dioxide Cells (Li/MnO2)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Implantable Cardiac Pacemakers (ICP)
9.10.2 Implantable Cardioverter Defibrillator (ICD)
9.10.3 Cardiac Resynchronization Therapy Devices (CRT-Ds)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Lithium-iodine Cells (Li/I2)
10.6.2 Lithium-silver Vanadium Oxide Cell (Li/SVO)
10.6.3 Lithium-carbon Mono-Fluoride Cells (Li/CFx)
10.6.4 Lithium-manganese Dioxide Cells (Li/MnO2)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Implantable Cardiac Pacemakers (ICP)
10.10.2 Implantable Cardioverter Defibrillator (ICD)
10.10.3 Cardiac Resynchronization Therapy Devices (CRT-Ds)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Lithium-iodine Cells (Li/I2)
11.6.2 Lithium-silver Vanadium Oxide Cell (Li/SVO)
11.6.3 Lithium-carbon Mono-Fluoride Cells (Li/CFx)
11.6.4 Lithium-manganese Dioxide Cells (Li/MnO2)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Implantable Cardiac Pacemakers (ICP)
11.10.2 Implantable Cardioverter Defibrillator (ICD)
11.10.3 Cardiac Resynchronization Therapy Devices (CRT-Ds)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Lithium-iodine Cells (Li/I2)
12.6.2 Lithium-silver Vanadium Oxide Cell (Li/SVO)
12.6.3 Lithium-carbon Mono-Fluoride Cells (Li/CFx)
12.6.4 Lithium-manganese Dioxide Cells (Li/MnO2)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Implantable Cardiac Pacemakers (ICP)
12.10.2 Implantable Cardioverter Defibrillator (ICD)
12.10.3 Cardiac Resynchronization Therapy Devices (CRT-Ds)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Lithium-iodine Cells (Li/I2)
13.6.2 Lithium-silver Vanadium Oxide Cell (Li/SVO)
13.6.3 Lithium-carbon Mono-Fluoride Cells (Li/CFx)
13.6.4 Lithium-manganese Dioxide Cells (Li/MnO2)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Implantable Cardiac Pacemakers (ICP)
13.10.2 Implantable Cardioverter Defibrillator (ICD)
13.10.3 Cardiac Resynchronization Therapy Devices (CRT-Ds)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Rhythm Management (CRM) Devices Batteries Market: Competitive Dashboard
14.2 Global Cardiac Rhythm Management (CRM) Devices Batteries Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Medtronic
14.3.3 SJM
14.3.4 EaglePicher
14.3.5 Integer
14.3.6 Boston Scientific